Palisade Bio, Inc. (PALI) NASDAQ

2.23

+0.08(+3.72%)

Updated at November 26 04:00PM

Currency In USD

Valuation

Market Cap2.34M
Enterprise Value-7.32M
P/E Ratio-1.48
PEG Ratio-0.03
Price/Sales Ratio5,085.61
Price/Book Ratio5.19
Enterprise/Revenue3,831.61
Enterprise/EBITDA-1.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-2,806.5
Operating Margin-2,864.25

Management Effectiveness

Return On Assets-1.61
Return On Equity-2.41

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-14.42M
Net Income-14.44M
Diluted EPS-10.19

Balance Sheet

Total Cash5.23M
Total Cash/Share0.7
Total Debt211,000
Total Debt/Equity0.07
Current Ratio1.96
Book Value Per Share0.43

Price History

52-Week Change-7.85
52-Week High3.3
52-Week Low0.53
Moving Average 50 Days1.65
Moving Average 200 Days1

Statistics

Average Volume7.72M
Shares Outstanding9.12M
% Held by Institutions17.25

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateApril 08, 2024